Shenzhen Salubris Pharmaceuticals Co. Ltd. (002294)
SZSE
30.40
+0.21 (+0.70%)
Closed
Sep 18, 2026
Day's Range
30.1230.70
52 wk Range
29.2570.99
Financial Statements - 002294 - Shenzhen Salubris Pharmaceuticals Co. Ltd.
Revenue
4.01B▲ 19.2%
Net Income
605.15M▲ 4.2%Net Margin 15.1%
EBITDA
1.21B▲ 14.8%
Free Cash Flow
561.44M▲ 233.3%
Income Statement
| Period Ending | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|---|---|
| Sales | 4.01B | 3.36B | 3.48B | 3.05B | 2.73B | 4.47B |
| Cost of Goods | 1.09B | 1.05B | 993.61M | 793.27M | 847.69M | 964.36M |
| Gross Profit | 2.91B | 2.30B | 2.48B | 2.26B | 1.89B | 3.50B |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | 771.19M | 643.25M | 632.48M | 577.14M | 368.37M | 886.17M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | - | - | - | - | - | - |
| Pre Tax Income | 632.51M | 641.76M | 713.72M | 599.84M | 56.74M | 851.34M |
| Income Tax | 27.36M | 60.93M | 79.35M | 71.52M | 6.60M | 169.50M |
| Net Income | 605.15M | 580.82M | 634.36M | 528.32M | 50.13M | 681.84M |
| EPS Basic | 0.54 | 0.52 | 0.58 | 0.5 | 0.06 | 0.68 |
| EPS Diluted | 0.54 | 0.52 | 0.58 | 0.5 | 0.06 | 0.68 |
| Basic Shares Outstanding | 1.11B | 1.11B | 1.09B | 1.06B | 1.01B | 1.05B |
| Diluted Shares Outstanding | 1.11B | 1.11B | 1.09B | 1.06B | 1.01B | 1.05B |
| Ebit | 648.68M | 659.13M | 726.26M | 610.36M | 74.31M | 867.35M |
| Ebitda | 1.21B | 1.05B | 1.09B | 1.07B | 594.74M | 1.10B |
| Net Income Continuous Operations | 605.15M | 580.82M | 634.36M | 528.32M | 50.13M | 681.84M |
| Minority Interests | -3.58M | -762.46K | 2.72M | 5.40M | 10.73M | 33.36M |
| Preferred Stock Dividends | 0 | 0 | 0 | 0 | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
